Paper Details

  1. Home
  2. Paper Details

Ribavirin with or without alpha interferon for chronic hepatitis C.

Author: GluudC, KjaergardL L, KrogsgaardK

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
ReviewAn article that critically examines existing research on a particular topic and summarizes the current state of knowledge in the field.
Systematic ReviewA review that systematically collects, evaluates, and integrates relevant research to answer a specific research question.

Overview

Hepatitis C is a serious liver disease. While a combination of ribavirin and interferon is currently the preferred treatment for those who have never received interferon, the effectiveness of this combination for patients who haven’t responded to interferon or have had the disease return is not clear.
Paper Details　
Original Abstract of the Article :
Hepatitis C is a major cause of liver-related morbidity and mortality. Ribavirin plus interferon combination therapy is presently considered the optimal treatment of interferon naive patients with chronic hepatitis C, but its role in relapsers and non-responders to previous interferon therapy is not...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1002/14651858.CD002234

データ提供：米国国立医学図書館（NLM）

Ribavirin and Interferon: A Powerful Duo for Chronic Hepatitis C

This research delves into the treatment of chronic hepatitis C, a serious liver disease. Researchers explored the effectiveness of ribavirin and interferon combination therapy in patients with chronic hepatitis C, specifically examining their role in patients who had previously relapsed or not responded to interferon therapy.

The Power of Combination Therapy: A New Frontier in Hepatitis C Treatment

This study suggests that ribavirin plus interferon combination therapy is the optimal treatment for interferon-naive patients with chronic hepatitis C. While further research is needed to confirm its efficacy in relapsers and non-responders, this approach offers a glimmer of hope for patients struggling with this challenging condition. Think of it like combining the strength of a camel caravan with the precision of a compass – together they can overcome the challenges of the desert.

Fighting Hepatitis C: A Journey Through the Medical Sands

This research highlights the importance of continuous research and innovation in the fight against chronic hepatitis C. While treatment options have improved significantly, further research is essential to discover new and effective treatments. It's a journey through the medical sands, seeking the most effective strategies to combat this formidable disease.

Dr.Camel's Conclusion

The quest for effective treatments for chronic hepatitis C continues, and this research offers a promising avenue for exploration. The combination of ribavirin and interferon holds potential, offering hope to patients facing this challenging condition. It's a testament to the enduring spirit of medical research, always striving to find new solutions in the face of adversity.

Date :
  1. Date Completed 2002-08-09
  2. Date Revised 2020-05-11
Further Info :

Pubmed ID

12076442

DOI: Digital Object Identifier

10.1002/14651858.CD002234

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.